- GlobeNewswire•2 hours agoEmergent BioSolutions Reports Fourth Quarter and Twelve Months 2016 Financial Results; Reaffirms 2017 Guidance and Provides 2020 Goals
GAITHERSBURG, Md., Feb. 23, 2017-- Emergent BioSolutions Inc. reported financial results for the quarter and twelve months ended December 31, 2016.. The presentation of Emergent’ s financial performance ...
- GlobeNewswire•10 days agoEmergent BioSolutions Receives BARDA Task Order Valued at Up to $30.5 Million to Develop Viral Hemorrhagic Fever Therapeutics
GAITHERSBURG, Md., Feb. 13, 2017-- Emergent BioSolutions Inc. today announced that it has received a task order from the Biomedical Advanced Research and Development Authority valued at up to $30.5 million ...
- GlobeNewswire•14 days agoEmergent BioSolutions to Release Fourth Quarter and Full Year 2016 Financial Results and Conduct a Conference Call on February 23, 2017
GAITHERSBURG, Md., Feb. 09, 2017-- Emergent BioSolutions Inc. will host a conference call on Thursday, February 23, 2017 at 5:00 pm to discuss the financial results for the fourth quarter and full twelve ...
EBS : Summary for Emergent Biosolutions, Inc. Com - Yahoo Finance
Emergent BioSolutions Inc. (EBS)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||29.35 - 30.26|
|52 Week Range||24.47 - 44.38|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||28.20|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|